News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,160 Results
Type
Article (42164)
Company Profile (294)
Press Release (669702)
Section
Business (210297)
Career Advice (2089)
Deals (36615)
Drug Delivery (105)
Drug Development (82949)
Employer Resources (172)
FDA (16530)
Job Trends (15381)
News (355739)
Policy (33857)
Tag
Academia (2579)
Alliances (51317)
Alzheimer's disease (1332)
Approvals (16511)
Artificial intelligence (214)
Bankruptcy (367)
Best Places to Work (11771)
Biotechnology (188)
Breast cancer (228)
Cancer (1741)
Cardiovascular disease (135)
Career advice (1746)
Cell therapy (357)
Clinical research (66791)
Collaboration (677)
Compensation (375)
COVID-19 (2634)
C-suite (163)
Data (1640)
Diabetes (214)
Diagnostics (6367)
Earnings (87127)
Employer resources (149)
Events (113726)
Executive appointments (577)
FDA (17447)
Funding (611)
Gene therapy (258)
GLP-1 (684)
Government (4478)
Healthcare (18949)
Infectious disease (2746)
Inflammatory bowel disease (124)
Interviews (321)
IPO (16737)
Job creations (4054)
Job search strategy (1490)
Layoffs (460)
Legal (8353)
Lung cancer (257)
Manufacturing (245)
Medical device (13347)
Medtech (13352)
Mergers & acquisitions (20245)
Metabolic disorders (568)
Neuroscience (1750)
NextGen: Class of 2025 (6634)
Non-profit (4523)
Northern California (2100)
Obesity (318)
Opinion (218)
Patents (166)
People (58797)
Phase I (20707)
Phase II (29400)
Phase III (22016)
Pipeline (717)
Postmarket research (2653)
Preclinical (8760)
Radiopharmaceuticals (246)
Rare diseases (336)
Real estate (6248)
Regulatory (22774)
Research institute (2360)
Resumes & cover letters (358)
Southern California (1801)
Startups (3717)
United States (18644)
Vaccines (631)
Weight loss (224)
Date
Today (81)
Last 7 days (593)
Last 30 days (2656)
Last 365 days (34971)
2025 (4501)
2024 (35769)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (779)
Arizona (218)
Asia (40385)
Australia (6469)
California (4794)
Canada (1723)
China (402)
Colorado (220)
Connecticut (231)
Europe (86059)
Florida (691)
Georgia (165)
Illinois (466)
Indiana (268)
Japan (125)
Maryland (747)
Massachusetts (3659)
Michigan (200)
Minnesota (336)
New Jersey (1362)
New York (1366)
North Carolina (852)
Northern California (2100)
Ohio (173)
Pennsylvania (1102)
South America (1159)
Southern California (1801)
Texas (711)
Utah (143)
Washington State (474)
712,160 Results for "aridis pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Aridis Provides Corporate Update - June 24, 2024
Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced a corporate update on recent developments.
June 24, 2024
·
8 min read
Press Releases
Aridis Provides Corporate Update
December 20, 2024
·
9 min read
Biotech Bay
Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until January 12, 2024
Aridis Pharmaceuticals, Inc. (OTC QB: ARDS) today announced that its 2023 Annual Meeting of Stockholders (“Annual Meeting”), scheduled for Friday, December 15, 2023, was convened and adjourned, without any business being conducted, due to lack of the requisite quorum.
December 15, 2023
·
6 min read
Business
Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update
Aridis Pharmaceuticals, Inc. (OTCQB: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today reported financial and corporate results for its third quarter ended September 30, 2023.
November 3, 2023
·
13 min read
Deals
Aridis Pharmaceuticals Announces $2 Million Offering
Aridis Pharmaceuticals, Inc. today announced the pricing of an offering of 10,000,000 shares of the Company’s common stock (or pre-funded warrants in lieu thereof) and accompanying warrants to purchase up to 10,000,000 shares of common stock at a combined offering price of $0.20 per share.
August 2, 2023
·
7 min read
Business
Aridis Pharmaceuticals Announces First Quarter 2023 Financial Results and Business Update
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today reported financial and corporate results for its first quarter ended March 31, 2023.
June 8, 2023
·
14 min read
Biotech Bay
Aridis Provides Corporate Update
Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced a corporate update on recent developments.
March 31, 2023
·
7 min read
Press Releases
Jabil Acquires Pharmaceutics International, Inc. (Pii)
February 4, 2025
·
4 min read
Press Releases
Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1%
February 13, 2025
·
1 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
1 of 71,216
Next
